Vascular endothelial cells and dysfunctions role of melatonin
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Several pathological conditions, including hypertension, atherosclerosis, diabetes, ischemia/reperfusion injury and nicotine-induced vasculopathy, are associated with vascular endothelial dysfunction characterized by altered secretory output of endothelial cells. Therefore there is a search for molecules and interventions that could restore endothelial function, in particular augmenting NO production, reducing the generation of free radicals and vasoconstrictors and preventing undesired inflammation. The pineal hormone melatonin exhibits several endothelium protective properties: it scavenges free radicals, activates antioxidant defence enzymes, normalizes lipid and blood pressure profile and increases NO bioavailability. Melatonin improved vascular function in experimental hypertension, reducing intimal infiltration and restoring NO production. Melatonin improved the NO pathway also in animal models for the study of diabetes and prevented NO down-regulation and adhesive molecules up-regulation in nicotine-induced vasculopathy. The protection against endothelial damage, vasoconstriction, platelet aggregation and leukocyte infiltration might contribute to the beneficial effects against ischemia-reperfusion injury by melatonin. Therefore, melatonin administration has endothelium-protective potential in several pathological conditions. Nevertheless, it still needs to be established, whether melatonin is able to revert already established endothelial dysfunction in these conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The clinical implications of endothelial dysfunction
Widlansky, M. E., Gokce, N., Keaney, J. F., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00994-x · Cited by 1,749 · cited 1×
“Hypertension is a major risk factor of severe cardiovascular complications (42, 54) and it is clearly associated with endothelial dysfunction (39, 55-57), augmented oxidative load and vascular inflammation (58, 59).”
BackgroundKim, J.-A., Montagnani, M., Koh, K. K., & Quon, M. J. (2006) · Circulation · doi:10.1161/circulationaha.105.563213 · Cited by 1,652
Ignarro, L. J., Lippton, H., Edwards, J. C., Baricos, W. H., Hyman, A. L., Kadowitz, P. J., & Gruetter, C. A. (1981) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32738-2 · Cited by 1,633 · cited 1×
“The primary mechanism by which NO relaxes vascular smooth muscle is by increasing intracellular cyclic GMP levels, followed by activation of protein kinase G and the subsequent phosphorylation of several regulatory proteins (50, 51).”
BackgroundOxidative Stress and Vascular Disease
Madamanchi, N. R., Vendrov, A., & Runge, M. S. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000150649.39934.13 · Cited by 1,618 · cited 1×
“The ROS may modify endothelial function by peroxidation of membrane lipids, activation of NF-κB, or by decreasing the NO availability (113).”
BackgroundTan, D., Manchester, L. C., Terron, M. P., Flores, L. J., & Reiter, R. J. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00407.x · Cited by 1,601 · cited 2×
“Melatonin and its metabolites have been shown to scavenge different types of free radicals in in vitro systems as well as in vivo, both in body fluids and in cells (21, 26, 27, 28).”
BackgroundCyclic guanosine monophosphate as a mediator of vasodilation.
Murad, F. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112536 · Cited by 799 · cited 1×
“The primary mechanism by which NO relaxes vascular smooth muscle is by increasing intracellular cyclic GMP levels, followed by activation of protein kinase G and the subsequent phosphorylation of several regulatory proteins (50, 51).”
BackgroundMelatonin, human aging, and age-related diseases
Karasek, M. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.04.012 · Cited by 380 · cited 1×
“It acts as sleep regulator (16), inhibits dopamine release in the hypothalamus and retina (17), it is involved in the aging process (18) and pubertal development (19), blood pressure control (20), free-radical scavenging (21) and regulation of the immune response (22).”
BackgroundMelatonin: A Pleiotropic Molecule Regulating Inflammation
Radogna, F., Diederich, M., & Ghibelli, L. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.041 · Cited by 342 · cited 1×
“Both effects allow melatonin to reduce the extent of reactive oxygen species (ROS), improving the outcomes of oxidative related pathologies such as hypertension (32), atherosclerosis (33), cancer (34), ischemia (35) or neurodegenerative diseases (36) and preventing aging (37, 38).”
BackgroundMelatonin, endocrine pancreas and diabetes
Peschke, E. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00519.x · Cited by 309 · cited 1×
“The antioxidant action might be responsible for the beneficial effect of melatonin, that normalized NO levels and lipid peroxides in a broad spectrum of diabetic models (104, 116-118).”
BackgroundEffects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men
Arangino, S., Cagnacci, A., Angiolucci, M., Vacca, A. M. B., Longu, G., Volpe, A., & Melis, G. B. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00112-5 · Cited by 200 · cited 1×
“The effects of melatonin on endothelium in hypertension Many experimental and clinical reports have supported the concept that melatonin has anti-hypertensive actions, influencing BP, regulating arterial vasodilatation and exerting protection against oxidative vascular disorders (47, 54, 67, 68-72).”
BackgroundMelatonin reduces night blood pressure in patients with nocturnal hypertension
Grossman, E., Laudon, M., Yalcin, R., Zengil, H., Peleg, E., Sharabi, Y., Kamari, Y., Shen-Orr, Z., & Zisapel, N. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.002 · Cited by 168
Antihypertensive Action of Melatonin in the Spontaneously Hypertensive Rat
Kawashima, K., Miwa, Y., Fujimoto, K., Oohata, H., Nishino, H., & Koike, H. (1987) · Clinical and Experimental Hypertension. Part A: Theory and Practice · doi:10.3109/10641968709160037 · Cited by 75 · cited 1×
“SHRs show EC dysfunction (81) and a more rapid decline of melatonin production with aging than normotensive rats (82).”
BackgroundInhibitory effects of melatonin on vascular reactivity: possible role of vasoactive mediators
Anwar, M. M., Meki, A.-R. M. A., & Abu Rahma, H. H. (2001) · Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology · doi:10.1016/s1532-0456(01)00261-7 · Cited by 60
Cited by
Melatonin as an antioxidant: under promises but over delivers
Reiter, R. J., Mayo, J. C., Tan, D., Sainz, R. M., Alatorre‐Jimenez, M., & Qin, L. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12360 · Cited by 1,703
Zhou, H., Li, D., Zhu, P., Hu, S., Hu, N., Ma, S., Zhang, Y., Han, T., Ren, J., Cao, F., et al. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12438 · Cited by 253
Endothelium and Its Alterations in Cardiovascular Diseases: Life Style Intervention
Favero, G., Paganelli, C., Buffoli, B., Rodella, L. F., & Rezzani, R. (2014) · BioMed Research International · doi:10.1155/2014/801896 · Cited by 252
Yang, Y., Sun, Y., Yi, W., Li, Y., Fan, C., Xin, Z., Jiang, S., Di, S., Qu, Y., Reiter, R. J., et al. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12175 · Cited by 171
“[104] reported that melatonin improved vascular function in experimental hypertension, reducing intimal infiltration and restoring NO production.”
BackgroundCicero, A. F. G., Grassi, D., Tocci, G., Galletti, F., Borghi, C., & Ferri, C. (2019) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-018-0296-6 · Cited by 79
Metadata
- Authors
- Rita, R.
- Venue
- Frontiers in Bioscience
- Publisher
- IMR Press
- Published
- 2013
- Volume
- E5
- Issue
- 1
- Pages
- 119-129
- ISSN
- 1944-7892 (ISSN-L)
- 1945-0494
- 1945-0508
- DOI
- 10.2741/e601
- OpenAlex
- W2321029188
- Cited by
- 57
- References
- 13
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.